Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China
State Ministry of Finance and State Ministry of Taxation announced that as of
products would be increased by two (2) percent. As a leading exporter of
medical dressing products in
(OTC Bulletin Board: WMDG; “Winner Medical”, or the “Company”) will greatly
benefit from this policy to reduce its cost and increase its profit.
This Government action would support the medical dressing industry in
the global market. It is also a national plan that the Government will
allocate funds to support the exporters to upgrade technology and develop
domestic brands.
During the first six months of fiscal year 2009, approximately 86% of the
Company’s revenue was attributed to export sales. Effective from
the tax rebate rate for exports of all the Company’s medical dressing products,
and also some types of medical equipment will increase from 13% to 15%; the
tax rebate rate for exports of the Company’s plastic and glass products will
increase from 11% to 13%.
About Winner Medical
Winner Medical is a leading manufacturer in the medical dressing industry
(medical and wound care products) in
Company has eight wholly-owned manufacturing and distribution facilities, four
joint-venture factories and over 5,000 employees. The Company engages in the
manufacture, sale, research, and development of medical care products, wound
care products, home care products and PurCotton products, a nonwoven fabric
made from 100% natural cotton. The products are sold worldwide, with
the U.S. and
holds 50 patents and patent applications in various products and manufacturing
processes and is one of the few Chinese companies licensed with the U.S. Food
and Drug Administration (FDA) to ship finished, sterilized products directly
to the U.S. market. To learn more about Winner Medical, visit Winner Medical’s
web site http://www.winnermedical.com .
Forward-Looking Statements
This press release contains certain statements that may include
“forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. All statements, other than statements of historical
fact included herein are “forward-looking statements” including statements
regarding Winner Medical and its subsidiary companies’ business strategy,
plans and objective and statements of non-historical information. These
forward looking statements are often identified by the use of forward-looking
terminology such as “believes,” “expects” or similar expressions, involve
known and unknown risks and uncertainties. Although Winner Medical believes
that the expectations reflected in these forward-looking statements are
reasonable, they do involve assumptions, risks and uncertainties, and these
expectations may prove to be incorrect. You should not place undue reliance on
these forward-looking statements, which speak only as of the date of this
press release. Winner Medical’s actual results could differ materially from
those anticipated in these forward-looking statements as a result of a variety
of factors, including those discussed in Winner Medical’s periodic reports
that are filed with and available from the Securities and Exchange Commission.
All forward-looking statements attributable to Winner Medical or persons
acting on its behalf are expressly qualified in their entirety by these
factors. Other than as required under the securities laws, Winner Medical does
not assume a duty to update these forward-looking statements.
Investor Relations Contacts:
Peng Zhai
Assistant Manager, Investor Relations
Winner Medical Group Inc.
Tel: +86-755-2806-6858
Email: investors@winnermedical.com
SOURCE Winner Medical Group Inc.